Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LB-HD-1 is a standardized botanical extract derived from the berries of the Oriental Raisin Tree (*Hovenia dulcis*), developed by Lifetree Biotech. Standardized to contain specific levels of quercetin, it is utilized for its hepatoprotective properties, particularly against alcohol-induced liver damage, as well as for fatigue relief and the enhancement of exercise capacity. In South Korea, LB-HD-1 is certified by the Ministry of Food and Drug Safety (MFDS) as a health functional food ingredient, having received certifications in 2008 and 2014. It is typically administered orally in powder form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LB-HD-1.